Acumen Pharmaceuticals In... (ABOS)
NASDAQ: ABOS
· Real-Time Price · USD
1.42
0.02 (1.43%)
At close: Aug 15, 2025, 3:59 PM
1.45
2.11%
After-hours: Aug 15, 2025, 07:52 PM EDT
Acumen Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -136.66M | -116.25M | -102.33M | -81.67M | -64.86M | -55.94M | -52.37M | -48.74M | -46.49M | -45.03M | -42.86M | -38.34M | -31.53M | -82.74M | -100.61M | -93.01M | -91.6M | -32.28M |
Depreciation & Amortization | -524K | 179K | 178K | 173K | 168K | 176K | 184K | 194K | 198K | 184K | 169K | 123K | 80K | 41K | 4K | 1K | n/a | n/a |
Stock-Based Compensation | 9.65M | 9.63M | 9.63M | 8.93M | 8.19M | 7.24M | 6.14M | 5.4M | 4.64M | 3.83M | 3.06M | 2.54M | 2M | 1.41M | 922K | 595K | 330K | 241K |
Other Working Capital | 12.97M | 10.38M | 7.38M | 8.51M | 2.7M | -2.54M | 4.13M | -652K | -400K | 4.5M | 3.43M | 5.54M | 2.31M | -1.32M | -259K | -4.26M | -744K | 859K |
Other Non-Cash Items | -1.1M | -4.39M | -5.35M | -4.23M | -3.99M | -2M | -888K | -1.43M | -531K | -63K | 487K | 711K | 515K | 58.29M | 81.29M | 80.57M | 81.42M | 23.71M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 134K | 134K | 134K | 134K | n/a | n/a | n/a |
Change in Working Capital | 10.87M | 8.36M | 11.65M | 9.49M | 4.87M | -225K | 3.87M | -1.37M | -44K | 4.05M | 3.99M | 7.24M | 2.71M | -1.03M | 298K | -5.33M | -75K | 1.4M |
Operating Cash Flow | -117.76M | -102.48M | -86.22M | -67.31M | -55.62M | -50.75M | -43.06M | -45.95M | -42.23M | -37.03M | -35.15M | -27.59M | -26.09M | -23.89M | -17.96M | -17.18M | -10.77M | -8M |
Capital Expenditures | -88K | -84K | -16K | -30K | -37K | -32K | -21K | -42K | -116K | -152K | -161K | -152K | -79K | -49K | -40K | -14K | -6K | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | 3K | 3K | 3K | 23.39K | 20.39K | 11.56K | 11.56K | -94.1M | -94.1M | -94.09M | -94.09M | n/a | n/a | n/a |
Purchase of Investments | -151.69M | -160.49M | -170.73M | -227.41M | -255.6M | -243.79M | -250.63M | -208.24M | -81.52M | -84.56M | -41.51M | -22.11M | -116.21M | -113.17M | -104.08M | -94.09M | n/a | n/a |
Sales Maturities Of Investments | 238.49M | 246.49M | 218.77M | 197M | 143.32M | 104.88M | 78.98M | 65M | 86.27M | 87.06M | 80.86M | -32.22M | -88.22M | -100.08M | -104.08M | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | -41.93K | -62.31K | -6.31K | 2.51K | -5.05M | 193.15M | 99M | 98.99M | 104.08M | -94.09M | n/a | n/a |
Investing Cash Flow | 86.7M | 85.92M | 48.03M | -30.44M | -112.31M | -138.95M | -171.67M | -143.28M | 4.64M | 2.36M | 39.19M | 49.59M | -100.43M | -109.22M | -104.12M | -94.11M | -6K | n/a |
Debt Repayment | -739K | -739K | -1.48M | 28.79M | 28.79M | 28.79M | 29.52M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -82K | -82K | -41K | -32K | -32K | -32K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 776K | 776K | 679K | -60K | -60K | -205K | -145K | 247K | -16K | 115K | 115K | -264K | 168.78M | 170.44M | 170.44M | 170.43M | 1.64M | n/a |
Financial Cash Flow | -87K | -215K | 6.93M | 36.07M | 158.88M | 158.86M | 151.75M | 126.8M | 3.78M | 3.91M | 3.91M | -267K | 168.78M | 200.47M | 200.47M | 245.13M | 76.35M | 44.67M |
Net Cash Flow | -31.15M | -16.77M | -31.26M | -61.69M | -9.06M | -30.84M | -62.98M | -62.43M | -33.82M | -30.77M | 7.94M | 21.74M | 42.26M | 67.36M | 78.39M | 133.84M | 65.57M | 36.67M |
Free Cash Flow | -117.85M | -102.56M | -86.23M | -67.34M | -55.66M | -50.78M | -43.09M | -45.99M | -42.35M | -37.18M | -35.31M | -27.74M | -26.17M | -23.94M | -18M | -17.19M | -10.78M | -8M |